Exploring periodontitis in patients with Chediak-Higashi syndrome

August 31, 2017, International & American Associations for Dental Research

The International and American Associations for Dental Research (IADR/AADR) have published an article titled "Periodontitis in Chédiak-Higashi Syndrome: An Altered Immunoinflammatory Response" in the JDR Clinical & Translational Research (JDR CTR). In this study, Vivek Thumbigere Math, from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), and authors from other institutes of NIH as well as the State University of Campinas, Piracicaba Dental School, Piracicaba, SP, Brazil sought to determine the periodontal status of patients with severe and mild forms of Chédiak-Higashi syndrome (CHS), a rare genetic disorder caused by mutations in the lysosomal trafficking regulator gene (LYST)—a gene that codes for a protein that helps with protein packaging and transport within cells.

Chédiak-Higashi syndrome is characterized by a type of albinism that affects the eyes, skin and hair as well as abnormal bleeding, recurrent bacterial infections, impaired immune and neurological function, and is often associated with aggressive periodontitis. Previous research suggests that LYST mutations affect toll-like receptors (TLRs), leading to frequent infections. TLRs comprise a family of proteins that normally senses bacterial threats and helps generate a host response to disease-causing bacteria.

This study investigated the periodontal status in with "classic" or more severe CHS, and patients with "atypical" or more moderate CHS. The researchers also examined the effect of LYST mutations on expression of two members of the TLR family, TLR-2 and TLR-4, and on the immune-regulating functions of gingival fibroblasts in CHS patients. Gingival fibroblasts help form the tooth-supporting gum tissue and secrete cytokines and other molecules that facilitate cell-to-cell communication. As a standard of care, all patients with classic CHS had undergone bone marrow transplantation (BMT), while none of the atypical CHS patients received BMT.

The authors noted that in contrast to aged-matched healthy individuals, atypical CHS patients and classic CHS patients exhibited mild chronic periodontitis with no evidence of gingival ulceration, severe tooth mobility, or premature exfoliation of teeth. Compared to gingival fibroblasts obtained from healthy donors, gingival fibroblasts obtained from classic CHS patients and atypical CHS patients displayed higher baseline expression of TLR-2 and lower baseline expression of TLR-4. When treated with extract from Fusobacterium nucleatum, a species of bacteria associated with periodontal disease, gingival fibroblasts from both classic and atypical CHS patients failed to increase production of TLR-2 and TLR-4 compared to the untreated or cells from healthy patients. Researchers also found that when exposed to F. nucleatum extract, gingival fibroblast cells from patients with atypical CHS expressed increased cytokine production compared to gingival fibroblast cells from classic CHS patients. These results suggest that LYST mutations may affect TLR-2 and TLR-4 expression and function, and lead to a dysregulated immunoinflammatory response, which in turn influences the periodontal disease phenotype noted in CHS patients.

"This study provides a better understanding of the molecular mechanisms governing the process and perhaps other situations in which the patients have altered TLRs and immune cell dysfunction," said JDR CTR Editor Jocelyne Feine. "This is also the first study to report the periodontal findings in atypical CHS patients and it raises new hypotheses for future research, plus the need for personalized intervention strategies tailored to an individual's host response."

This study can be used to create awareness among clinicians and researchers that not all CHS patients exhibit historically reported aggressive periodontitis. The results also show that periodontitis susceptibility in CHS is mainly mediated by hematopoietic cells—the cells that give rise to immune cells and other blood cells—and that classic CHS patients who underwent a bone marrow transplant early in life and atypical CHS patients are less susceptible to aggressive periodontitis when compared with classic CHS patients who never receive BMT.

The investigators of this study express their sincere gratitude to research patients and their families, as well as the grant funding institutions. The study was supported by the NIAMS (under award numbers ZIAAR041196 and K99AR069643), the National Human Genome Research Institute, and the National Institute of Allergy and Infectious Diseases.

Explore further: IADR/AADR publish study on obesity link to periodontitis

More information: V. Thumbigere Math et al, Periodontitis in Chédiak-Higashi Syndrome: An Altered Immunoinflammatory Response, JDR Clinical & Translational Research (2017). DOI: 10.1177/2380084417724117

Related Stories

IADR/AADR publish study on obesity link to periodontitis

October 31, 2011
In a study titled "MicroRNA Modulation in Obesity and Periodontitis," lead author Romina Perri, University of North Carolina School of Dentistry, Oral Health Institute, conducted a pilot investigation to determine whether ...

Severe gum disease strongly predicts higher mortality in cirrhosis

April 20, 2017
Results presented today from a prospective study in patients with irreversible scarring of the liver (cirrhosis) demonstrates that severe periodontitis (an inflammatory gum disease) strongly predicts higher mortality in this ...

Genetic signature reveals new way to classify gum disease

March 21, 2014
Researchers at Columbia University Medical Center (CUMC) have devised a new system for classifying periodontal disease based on the genetic signature of affected tissue, rather than on clinical signs and symptoms. The new ...

Non-inflammatory destructive periodontal disease

April 20, 2016
Although, bacteria are a critical etiologic factor that are needed to develop periodontal disease, bacteria alone are insuficiente to induce a periodontal disease. A susceptible host is also required, and the host's susceptibility ...

Inflammation in the mouth and joints in rheumatoid arthritis

March 12, 2015
Today at the 93rd General Session and Exhibition of the International Association for Dental Research, researcher Sheila Arvikar, Massachusetts General Hospital, Boston, USA, will present a study titled "Inflammation in the ...

Researchers reverse bone loss in immune disorder

March 26, 2014
Patients with leukocyte adhesion deficiency, or LAD, suffer from frequent bacterial infections, including the severe gum disease known as periodontitis. These patients often lose their teeth early in life.

Recommended for you

Painless dental lasers can render teeth cavity-resistant

November 21, 2017
Almost as soon as lasers were invented in the 1960s, curious dentists wondered if these powerful forms of light could be used on teeth, though those early lasers were much too crude for any useful dental work.

Nanodiamonds show promise for aiding recovery from root canal

October 23, 2017
People who undergo root canals may soon have a tiny but powerful ally that could prevent infection after treatment.

Research shows aspirin could repair tooth decay

September 8, 2017
Researchers at Queen's University Belfast have discovered that aspirin could reverse the effects of tooth decay resulting in a reduction in the need for fillings. Currently about 7 million fillings are provided by the NHS ...

New dental imaging method uses squid ink to fish for gum disease

September 7, 2017
Squid ink might be a great ingredient to make black pasta, but it could also one day make getting checked for gum disease at the dentist less tedious and even painless. By combining squid ink with light and ultrasound, a ...

A new dental restoration composite proves more durable than the conventional material

August 21, 2017
Fewer trips to the dentist may be in your future, and you have mussels to thank.

Small molecule inhibitor prevents or impedes tooth cavities in a preclinical model

August 10, 2017
University of Alabama at Birmingham researchers have created a small molecule that prevents or impedes tooth cavities in a preclinical model. The inhibitor blocks the function of a key virulence enzyme in an oral bacterium, ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.